Ahead of the second Stellar StartUps competition in September, Philadelphia Media Network is showcasing King of Prussia’s Trice Medical as the type of successful new enterprise it hopes to cultivate in the Philadelphia region, writes Diane Mastrull for Philly.com.
Five-year-old Trice Medical is the developer of mi-eye 2. This provides a cheaper and faster alternative to MRI’s in the diagnosis of joint injuries.
The device uses a hypodermic needle with a small camera tethered to a Microsoft Surface tablet. It can be used by doctors on orthopedic patients to diagnose injuries such as a torn ACL or meniscus.
The device also costs around a third of an MRI machine and the other main advantage of mi-eye 2, is that there is no need for a trip to the hospital or other imaging facility. My-eye 2 has already received FDA approval and was launched on the market earlier this year.
Since then, it has been used an estimated 3,000 times, with that number expected to grow to over 10,000 by the end of the year.
Jeffrey O’Donnell, President and CEO of Trice Medical said that he is very happy with the progress. “I’m here to stay,” he said.
Read more about the competition at Philly.com by clicking here.